Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

08/08/2024 08:30

Aug 8 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Sep 30, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             33.16               29.48            46.06    
                 (+12.5 pct)         (+11.4 pct)      (+12.6 pct) 
  Operating          2.22                2.40             3.99    
                 (-7.8 pct)          (-33.5 pct)      (+3.4 pct)  
  Recurring          2.97                2.74             4.60    
                 (+8.3 pct)          (-28.4 pct)      (+1.8 pct)  
  Net                4.91                1.98             6.19    
                (+147.7 pct)         (-25.0 pct)      (+80.0 pct) 
  EPS            201.98 yen           81.58 yen       254.51 yen  
  Ann Div                             37.00 yen        42.50 yen  
  -Q2 div         20.00 yen           17.00 yen                   
  -Q4 div                             20.00 yen        22.50 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T